Concepedia

Donald Bankston

DB

Statistics

Publications

9

Citations

380

H-Index

9

Active since

1989

Affiliations

Bayer (United States)(Current)

Burroughs Wellcome Fund

Bayer (Germany)

Research Triangle Park Foundation

Donald Bankston is an author at Bayer (United States) specializing in medicinal chemistry, pharmacology, and chemistry.

Publications per year

1989–2004

9

Publications

9

A Scaleable Synthesis of BAY 43-9006:  A Potent Raf Kinase Inhibitor for the Treatment of Cancer

Donald Bankston, Jacques Dumas, Reina Natero et al. · Organic Process Research & Development · 2002 · 112 citations

, , +11

2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase

Todd A. Blumenkopf, Joan A. Harrington, Cecilia S. Koble et al. · Journal of Medicinal Chemistry · 1992 · 63 citations

, , +8

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors

Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

, , +9

Convergent catalytic asymmetric synthesis of camptothecin analog GI147211C

Francis G. Fang, Donald Bankston, Edward M. Huie et al. · Tetrahedron · 1997 · 38 citations

, , +12

Palladium(II) Acetate−Tris(triphenylphosphine)rhodium(I) Chloride:  A Novel Catalytic Couple for the Intramolecular Heck Reaction

Donald Bankston, Frank Fang, Edward M. Huie et al. · The Journal of Organic Chemistry · 1999 · 35 citations

, , +13

1–5 of 9